Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Helicore Biopharma

Request full access

Biopharmaceutical solutions focused on discovering and developing weight-loss therapeutics

San Mateo, United StatesFounded 2023Biotech & Life Sciences

About Helicore Biopharma

Helicore Biopharma, Inc. is a biopharmaceutical company at the forefront of developing novel weight loss therapeutics. The company is focused on the discovery and advancement of innovative treatments for obesity, primarily through its lead candidate, HCR 188. This first-in-class biologic GIP antagonist offers a differentiated mechanism of action, targeting the elevation of nutrient-stimulated glucose-dependent insulinotropic polypeptide (GIP) levels. By directly binding to the hormone, HCR 188 functionally neutralizes active GIP in circulation, aiming to reverse the physiological underpinnings of obesity. Helicore's approach seeks to mitigate the chronic effects of dysregulated GIP signaling, which can lead to glucose intolerance and insulin resistance, ultimately driving obesity. The company operates in the biopharmaceutical market, serving healthcare providers and patients seeking effective weight loss solutions. Helicore's business model involves advancing its therapeutic candidates through clinical trials, with plans to enter the clinic by early 2025. Revenue generation is anticipated through successful commercialization of its therapies post-clinical validation. The company recently secured $65 million in Series A financing, underscoring investor confidence in its potential to address significant unmet needs in obesity treatment.

Source: Dealroom company data

At a glance

Status
Operational
Employees
7
Open positions
None listed
Dealroom signal
58.7/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Medical Research, Weight Management, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

1 recorded event

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Jan 2025 $65M $260M Longitude Capital · Wellington Management · OrbiMed · Versant Ventures ↗
Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Helicore Biopharma website traffic

Latest recorded traffic for Helicore Biopharma is 260 monthly website visits, down 90.7% over the last three months. Helicore Biopharma's team grew 0% over the past year.

Latest monthly visits260 3-month web change-90.7% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Helicore Biopharma in the San Mateo ecosystem

Live from Dealroom

The Helicore Biopharma office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

4 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

Team profiled 2 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States80%
🇪🇸 Spain20%
2 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Helicore Biopharma on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Helicore Biopharma’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.